Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verona Pharma plc

72.73
+0.47000.65%
Post-market: 72.730.00000.00%19:54 EDT
Volume:1.45M
Turnover:105.46M
Market Cap:6.19B
PE:-36.05
High:73.93
Open:72.74
Low:71.19
Close:72.26
Loading ...

European Equities Traded in the US as American Depositary Receipts Climb Higher in Thursday Trading

MT Newswires Live
·
31 Jan

Here's Why 'Trend' Investors Would Love Betting on Verona Pharma (VRNA)

Zacks
·
27 Jan

Verona Pharma Price Target Raised to $60.00/Share From $42.00 by HC Wainwright & Co.

Dow Jones
·
21 Jan

Verona Pharma Plc : H.c. Wainwright Raises Target Price to $60 From $42

THOMSON REUTERS
·
21 Jan

Is Verona Pharma (VRNA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?

Insider Monkey
·
21 Jan

European Equities Traded in the US as American Depositary Receipts Rise Thursday

MT Newswires Live
·
17 Jan

Wall Street Analysts See a 30.65% Upside in Verona Pharma (VRNA): Can the Stock Really Move This High?

Zacks
·
14 Jan

European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading

MT Newswires Live
·
14 Jan

U.S. RESEARCH ROUNDUP- Constellation Brands, Merck, WD-40

Reuters
·
13 Jan

Verona Pharma Plc : Jefferies Raises Target Price to $70 From $50

THOMSON REUTERS
·
13 Jan

Verona Pharma (VRNA) Upgraded to Buy: What Does It Mean for the Stock?

Zacks
·
11 Jan

Roth Initiates Verona Pharma at Buy

MT Newswires Live
·
10 Jan

Stock Track | Verona Pharma Plunges 5.95% Despite Analyst Expectations of Profitability in 2026

Stock Track
·
10 Jan

Analysts Expect Breakeven For Verona Pharma plc (NASDAQ:VRNA) Before Long

Simply Wall St.
·
10 Jan

Verona Pharma (VRNA) is on the Move, Here's Why the Trend Could be Sustainable

Zacks
·
10 Jan

Verona Pharma initiated with a Buy at Roth MKM

TIPRANKS
·
10 Jan

Stock Track | Verona Pharma Soars 5.19% in Pre-market Trading on Analyst's Buy Rating for COPD Drug

Stock Track
·
10 Jan

Verona Pharma’s Ohtuvayre: Unique COPD Solution Drives Buy Rating Amid Market Potential and Revenue Growth

TIPRANKS
·
10 Jan

Verona Pharma Plc : Piper Sandler Raises Target Price to $76 From $36

THOMSON REUTERS
·
09 Jan

Verona Pharma Price Target Raised to $57.00/Share From $44.00 by Truist Securities

Dow Jones
·
08 Jan